Pharma & Healthcare
Global Drugs for Asthma and COPD Market Research Report 2025
- Sep 09, 25
- ID: 497270
- Pages: 82
- Figures: 87
- Views: 4
This report aims to provide a comprehensive presentation of the global market for Drugs for Asthma and COPD, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Asthma and COPD.
The Drugs for Asthma and COPD market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Asthma and COPD market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Asthma and COPD companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco
Segment by Type
Inhalable & Nasal Spray
Oral
Others
Segment by Application
Asthma
COPD
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Asthma and COPD company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Drugs for Asthma and COPD market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Asthma and COPD market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Asthma and COPD companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco
Segment by Type
Inhalable & Nasal Spray
Oral
Others
Segment by Application
Asthma
COPD
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Asthma and COPD company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Asthma and COPD Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inhalable & Nasal Spray
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Drugs for Asthma and COPD Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Asthma
1.3.3 COPD
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Asthma and COPD Market Perspective (2020-2031)
2.2 Global Drugs for Asthma and COPD Growth Trends by Region
2.2.1 Global Drugs for Asthma and COPD Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drugs for Asthma and COPD Historic Market Size by Region (2020-2025)
2.2.3 Drugs for Asthma and COPD Forecasted Market Size by Region (2026-2031)
2.3 Drugs for Asthma and COPD Market Dynamics
2.3.1 Drugs for Asthma and COPD Industry Trends
2.3.2 Drugs for Asthma and COPD Market Drivers
2.3.3 Drugs for Asthma and COPD Market Challenges
2.3.4 Drugs for Asthma and COPD Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Asthma and COPD Players by Revenue
3.1.1 Global Top Drugs for Asthma and COPD Players by Revenue (2020-2025)
3.1.2 Global Drugs for Asthma and COPD Revenue Market Share by Players (2020-2025)
3.2 Global Drugs for Asthma and COPD Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drugs for Asthma and COPD Revenue
3.4 Global Drugs for Asthma and COPD Market Concentration Ratio
3.4.1 Global Drugs for Asthma and COPD Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Asthma and COPD Revenue in 2024
3.5 Global Key Players of Drugs for Asthma and COPD Head office and Area Served
3.6 Global Key Players of Drugs for Asthma and COPD, Product and Application
3.7 Global Key Players of Drugs for Asthma and COPD, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Asthma and COPD Breakdown Data by Type
4.1 Global Drugs for Asthma and COPD Historic Market Size by Type (2020-2025)
4.2 Global Drugs for Asthma and COPD Forecasted Market Size by Type (2026-2031)
5 Drugs for Asthma and COPD Breakdown Data by Application
5.1 Global Drugs for Asthma and COPD Historic Market Size by Application (2020-2025)
5.2 Global Drugs for Asthma and COPD Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drugs for Asthma and COPD Market Size (2020-2031)
6.2 North America Drugs for Asthma and COPD Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drugs for Asthma and COPD Market Size by Country (2020-2025)
6.4 North America Drugs for Asthma and COPD Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Asthma and COPD Market Size (2020-2031)
7.2 Europe Drugs for Asthma and COPD Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drugs for Asthma and COPD Market Size by Country (2020-2025)
7.4 Europe Drugs for Asthma and COPD Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Asthma and COPD Market Size (2020-2031)
8.2 Asia-Pacific Drugs for Asthma and COPD Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drugs for Asthma and COPD Market Size by Region (2020-2025)
8.4 Asia-Pacific Drugs for Asthma and COPD Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Asthma and COPD Market Size (2020-2031)
9.2 Latin America Drugs for Asthma and COPD Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drugs for Asthma and COPD Market Size by Country (2020-2025)
9.4 Latin America Drugs for Asthma and COPD Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Asthma and COPD Market Size (2020-2031)
10.2 Middle East & Africa Drugs for Asthma and COPD Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2020-2025)
10.4 Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Drugs for Asthma and COPD Introduction
11.1.4 GSK Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.1.5 GSK Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Drugs for Asthma and COPD Introduction
11.2.4 AstraZeneca Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Drugs for Asthma and COPD Introduction
11.3.4 Boehringer Ingelheim Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Vertex
11.4.1 Vertex Company Details
11.4.2 Vertex Business Overview
11.4.3 Vertex Drugs for Asthma and COPD Introduction
11.4.4 Vertex Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.4.5 Vertex Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Drugs for Asthma and COPD Introduction
11.5.4 Roche Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Drugs for Asthma and COPD Introduction
11.6.4 Novartis Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Drugs for Asthma and COPD Introduction
11.7.4 Teva Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.7.5 Teva Recent Development
11.8 Chiesi
11.8.1 Chiesi Company Details
11.8.2 Chiesi Business Overview
11.8.3 Chiesi Drugs for Asthma and COPD Introduction
11.8.4 Chiesi Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.8.5 Chiesi Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Drugs for Asthma and COPD Introduction
11.9.4 Mylan Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.9.5 Mylan Recent Development
11.10 Sumitomo Dainippon
11.10.1 Sumitomo Dainippon Company Details
11.10.2 Sumitomo Dainippon Business Overview
11.10.3 Sumitomo Dainippon Drugs for Asthma and COPD Introduction
11.10.4 Sumitomo Dainippon Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.10.5 Sumitomo Dainippon Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Drugs for Asthma and COPD Introduction
11.11.4 Merck Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.11.5 Merck Recent Development
11.12 Beximco
11.12.1 Beximco Company Details
11.12.2 Beximco Business Overview
11.12.3 Beximco Drugs for Asthma and COPD Introduction
11.12.4 Beximco Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.12.5 Beximco Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Asthma and COPD Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inhalable & Nasal Spray
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Drugs for Asthma and COPD Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Asthma
1.3.3 COPD
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Asthma and COPD Market Perspective (2020-2031)
2.2 Global Drugs for Asthma and COPD Growth Trends by Region
2.2.1 Global Drugs for Asthma and COPD Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drugs for Asthma and COPD Historic Market Size by Region (2020-2025)
2.2.3 Drugs for Asthma and COPD Forecasted Market Size by Region (2026-2031)
2.3 Drugs for Asthma and COPD Market Dynamics
2.3.1 Drugs for Asthma and COPD Industry Trends
2.3.2 Drugs for Asthma and COPD Market Drivers
2.3.3 Drugs for Asthma and COPD Market Challenges
2.3.4 Drugs for Asthma and COPD Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Asthma and COPD Players by Revenue
3.1.1 Global Top Drugs for Asthma and COPD Players by Revenue (2020-2025)
3.1.2 Global Drugs for Asthma and COPD Revenue Market Share by Players (2020-2025)
3.2 Global Drugs for Asthma and COPD Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drugs for Asthma and COPD Revenue
3.4 Global Drugs for Asthma and COPD Market Concentration Ratio
3.4.1 Global Drugs for Asthma and COPD Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Asthma and COPD Revenue in 2024
3.5 Global Key Players of Drugs for Asthma and COPD Head office and Area Served
3.6 Global Key Players of Drugs for Asthma and COPD, Product and Application
3.7 Global Key Players of Drugs for Asthma and COPD, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Asthma and COPD Breakdown Data by Type
4.1 Global Drugs for Asthma and COPD Historic Market Size by Type (2020-2025)
4.2 Global Drugs for Asthma and COPD Forecasted Market Size by Type (2026-2031)
5 Drugs for Asthma and COPD Breakdown Data by Application
5.1 Global Drugs for Asthma and COPD Historic Market Size by Application (2020-2025)
5.2 Global Drugs for Asthma and COPD Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drugs for Asthma and COPD Market Size (2020-2031)
6.2 North America Drugs for Asthma and COPD Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drugs for Asthma and COPD Market Size by Country (2020-2025)
6.4 North America Drugs for Asthma and COPD Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Asthma and COPD Market Size (2020-2031)
7.2 Europe Drugs for Asthma and COPD Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drugs for Asthma and COPD Market Size by Country (2020-2025)
7.4 Europe Drugs for Asthma and COPD Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Asthma and COPD Market Size (2020-2031)
8.2 Asia-Pacific Drugs for Asthma and COPD Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drugs for Asthma and COPD Market Size by Region (2020-2025)
8.4 Asia-Pacific Drugs for Asthma and COPD Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Asthma and COPD Market Size (2020-2031)
9.2 Latin America Drugs for Asthma and COPD Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drugs for Asthma and COPD Market Size by Country (2020-2025)
9.4 Latin America Drugs for Asthma and COPD Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Asthma and COPD Market Size (2020-2031)
10.2 Middle East & Africa Drugs for Asthma and COPD Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2020-2025)
10.4 Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Drugs for Asthma and COPD Introduction
11.1.4 GSK Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.1.5 GSK Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Drugs for Asthma and COPD Introduction
11.2.4 AstraZeneca Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Drugs for Asthma and COPD Introduction
11.3.4 Boehringer Ingelheim Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Vertex
11.4.1 Vertex Company Details
11.4.2 Vertex Business Overview
11.4.3 Vertex Drugs for Asthma and COPD Introduction
11.4.4 Vertex Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.4.5 Vertex Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Drugs for Asthma and COPD Introduction
11.5.4 Roche Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Drugs for Asthma and COPD Introduction
11.6.4 Novartis Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Drugs for Asthma and COPD Introduction
11.7.4 Teva Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.7.5 Teva Recent Development
11.8 Chiesi
11.8.1 Chiesi Company Details
11.8.2 Chiesi Business Overview
11.8.3 Chiesi Drugs for Asthma and COPD Introduction
11.8.4 Chiesi Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.8.5 Chiesi Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Drugs for Asthma and COPD Introduction
11.9.4 Mylan Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.9.5 Mylan Recent Development
11.10 Sumitomo Dainippon
11.10.1 Sumitomo Dainippon Company Details
11.10.2 Sumitomo Dainippon Business Overview
11.10.3 Sumitomo Dainippon Drugs for Asthma and COPD Introduction
11.10.4 Sumitomo Dainippon Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.10.5 Sumitomo Dainippon Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Drugs for Asthma and COPD Introduction
11.11.4 Merck Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.11.5 Merck Recent Development
11.12 Beximco
11.12.1 Beximco Company Details
11.12.2 Beximco Business Overview
11.12.3 Beximco Drugs for Asthma and COPD Introduction
11.12.4 Beximco Revenue in Drugs for Asthma and COPD Business (2020-2025)
11.12.5 Beximco Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drugs for Asthma and COPD Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Inhalable & Nasal Spray
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Drugs for Asthma and COPD Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drugs for Asthma and COPD Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Drugs for Asthma and COPD Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Drugs for Asthma and COPD Market Share by Region (2020-2025)
Table 9. Global Drugs for Asthma and COPD Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Drugs for Asthma and COPD Market Share by Region (2026-2031)
Table 11. Drugs for Asthma and COPD Market Trends
Table 12. Drugs for Asthma and COPD Market Drivers
Table 13. Drugs for Asthma and COPD Market Challenges
Table 14. Drugs for Asthma and COPD Market Restraints
Table 15. Global Drugs for Asthma and COPD Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Drugs for Asthma and COPD Market Share by Players (2020-2025)
Table 17. Global Top Drugs for Asthma and COPD Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Asthma and COPD as of 2024)
Table 18. Ranking of Global Top Drugs for Asthma and COPD Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Drugs for Asthma and COPD Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Drugs for Asthma and COPD, Headquarters and Area Served
Table 21. Global Key Players of Drugs for Asthma and COPD, Product and Application
Table 22. Global Key Players of Drugs for Asthma and COPD, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs for Asthma and COPD Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Drugs for Asthma and COPD Revenue Market Share by Type (2020-2025)
Table 26. Global Drugs for Asthma and COPD Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Drugs for Asthma and COPD Revenue Market Share by Type (2026-2031)
Table 28. Global Drugs for Asthma and COPD Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Drugs for Asthma and COPD Revenue Market Share by Application (2020-2025)
Table 30. Global Drugs for Asthma and COPD Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Drugs for Asthma and COPD Revenue Market Share by Application (2026-2031)
Table 32. North America Drugs for Asthma and COPD Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Drugs for Asthma and COPD Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Drugs for Asthma and COPD Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Drugs for Asthma and COPD Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Drugs for Asthma and COPD Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Drugs for Asthma and COPD Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Drugs for Asthma and COPD Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Drugs for Asthma and COPD Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Drugs for Asthma and COPD Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Drugs for Asthma and COPD Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Drugs for Asthma and COPD Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Drugs for Asthma and COPD Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Drugs for Asthma and COPD Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2026-2031) & (US$ Million)
Table 47. GSK Company Details
Table 48. GSK Business Overview
Table 49. GSK Drugs for Asthma and COPD Product
Table 50. GSK Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 51. GSK Recent Development
Table 52. AstraZeneca Company Details
Table 53. AstraZeneca Business Overview
Table 54. AstraZeneca Drugs for Asthma and COPD Product
Table 55. AstraZeneca Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 56. AstraZeneca Recent Development
Table 57. Boehringer Ingelheim Company Details
Table 58. Boehringer Ingelheim Business Overview
Table 59. Boehringer Ingelheim Drugs for Asthma and COPD Product
Table 60. Boehringer Ingelheim Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 61. Boehringer Ingelheim Recent Development
Table 62. Vertex Company Details
Table 63. Vertex Business Overview
Table 64. Vertex Drugs for Asthma and COPD Product
Table 65. Vertex Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 66. Vertex Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Drugs for Asthma and COPD Product
Table 70. Roche Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Drugs for Asthma and COPD Product
Table 75. Novartis Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Teva Company Details
Table 78. Teva Business Overview
Table 79. Teva Drugs for Asthma and COPD Product
Table 80. Teva Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 81. Teva Recent Development
Table 82. Chiesi Company Details
Table 83. Chiesi Business Overview
Table 84. Chiesi Drugs for Asthma and COPD Product
Table 85. Chiesi Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 86. Chiesi Recent Development
Table 87. Mylan Company Details
Table 88. Mylan Business Overview
Table 89. Mylan Drugs for Asthma and COPD Product
Table 90. Mylan Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 91. Mylan Recent Development
Table 92. Sumitomo Dainippon Company Details
Table 93. Sumitomo Dainippon Business Overview
Table 94. Sumitomo Dainippon Drugs for Asthma and COPD Product
Table 95. Sumitomo Dainippon Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 96. Sumitomo Dainippon Recent Development
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Drugs for Asthma and COPD Product
Table 100. Merck Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Beximco Company Details
Table 103. Beximco Business Overview
Table 104. Beximco Drugs for Asthma and COPD Product
Table 105. Beximco Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 106. Beximco Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Drugs for Asthma and COPD Picture
Figure 2. Global Drugs for Asthma and COPD Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drugs for Asthma and COPD Market Share by Type: 2024 VS 2031
Figure 4. Inhalable & Nasal Spray Features
Figure 5. Oral Features
Figure 6. Others Features
Figure 7. Global Drugs for Asthma and COPD Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Drugs for Asthma and COPD Market Share by Application: 2024 VS 2031
Figure 9. Asthma Case Studies
Figure 10. COPD Case Studies
Figure 11. Drugs for Asthma and COPD Report Years Considered
Figure 12. Global Drugs for Asthma and COPD Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Drugs for Asthma and COPD Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Drugs for Asthma and COPD Market Share by Region: 2024 VS 2031
Figure 15. Global Drugs for Asthma and COPD Market Share by Players in 2024
Figure 16. Global Top Drugs for Asthma and COPD Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Asthma and COPD as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Drugs for Asthma and COPD Revenue in 2024
Figure 18. North America Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Drugs for Asthma and COPD Market Share by Country (2020-2031)
Figure 20. United States Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Drugs for Asthma and COPD Market Share by Country (2020-2031)
Figure 24. Germany Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Drugs for Asthma and COPD Market Share by Region (2020-2031)
Figure 32. China Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Drugs for Asthma and COPD Market Share by Country (2020-2031)
Figure 40. Mexico Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Drugs for Asthma and COPD Market Share by Country (2020-2031)
Figure 44. Turkey Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. GSK Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 48. AstraZeneca Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 50. Vertex Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 51. Roche Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 53. Teva Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 54. Chiesi Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 55. Mylan Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 56. Sumitomo Dainippon Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 57. Merck Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 58. Beximco Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Drugs for Asthma and COPD Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Inhalable & Nasal Spray
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Drugs for Asthma and COPD Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drugs for Asthma and COPD Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Drugs for Asthma and COPD Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Drugs for Asthma and COPD Market Share by Region (2020-2025)
Table 9. Global Drugs for Asthma and COPD Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Drugs for Asthma and COPD Market Share by Region (2026-2031)
Table 11. Drugs for Asthma and COPD Market Trends
Table 12. Drugs for Asthma and COPD Market Drivers
Table 13. Drugs for Asthma and COPD Market Challenges
Table 14. Drugs for Asthma and COPD Market Restraints
Table 15. Global Drugs for Asthma and COPD Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Drugs for Asthma and COPD Market Share by Players (2020-2025)
Table 17. Global Top Drugs for Asthma and COPD Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Asthma and COPD as of 2024)
Table 18. Ranking of Global Top Drugs for Asthma and COPD Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Drugs for Asthma and COPD Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Drugs for Asthma and COPD, Headquarters and Area Served
Table 21. Global Key Players of Drugs for Asthma and COPD, Product and Application
Table 22. Global Key Players of Drugs for Asthma and COPD, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs for Asthma and COPD Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Drugs for Asthma and COPD Revenue Market Share by Type (2020-2025)
Table 26. Global Drugs for Asthma and COPD Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Drugs for Asthma and COPD Revenue Market Share by Type (2026-2031)
Table 28. Global Drugs for Asthma and COPD Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Drugs for Asthma and COPD Revenue Market Share by Application (2020-2025)
Table 30. Global Drugs for Asthma and COPD Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Drugs for Asthma and COPD Revenue Market Share by Application (2026-2031)
Table 32. North America Drugs for Asthma and COPD Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Drugs for Asthma and COPD Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Drugs for Asthma and COPD Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Drugs for Asthma and COPD Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Drugs for Asthma and COPD Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Drugs for Asthma and COPD Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Drugs for Asthma and COPD Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Drugs for Asthma and COPD Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Drugs for Asthma and COPD Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Drugs for Asthma and COPD Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Drugs for Asthma and COPD Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Drugs for Asthma and COPD Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Drugs for Asthma and COPD Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Drugs for Asthma and COPD Market Size by Country (2026-2031) & (US$ Million)
Table 47. GSK Company Details
Table 48. GSK Business Overview
Table 49. GSK Drugs for Asthma and COPD Product
Table 50. GSK Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 51. GSK Recent Development
Table 52. AstraZeneca Company Details
Table 53. AstraZeneca Business Overview
Table 54. AstraZeneca Drugs for Asthma and COPD Product
Table 55. AstraZeneca Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 56. AstraZeneca Recent Development
Table 57. Boehringer Ingelheim Company Details
Table 58. Boehringer Ingelheim Business Overview
Table 59. Boehringer Ingelheim Drugs for Asthma and COPD Product
Table 60. Boehringer Ingelheim Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 61. Boehringer Ingelheim Recent Development
Table 62. Vertex Company Details
Table 63. Vertex Business Overview
Table 64. Vertex Drugs for Asthma and COPD Product
Table 65. Vertex Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 66. Vertex Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Drugs for Asthma and COPD Product
Table 70. Roche Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Drugs for Asthma and COPD Product
Table 75. Novartis Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Teva Company Details
Table 78. Teva Business Overview
Table 79. Teva Drugs for Asthma and COPD Product
Table 80. Teva Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 81. Teva Recent Development
Table 82. Chiesi Company Details
Table 83. Chiesi Business Overview
Table 84. Chiesi Drugs for Asthma and COPD Product
Table 85. Chiesi Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 86. Chiesi Recent Development
Table 87. Mylan Company Details
Table 88. Mylan Business Overview
Table 89. Mylan Drugs for Asthma and COPD Product
Table 90. Mylan Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 91. Mylan Recent Development
Table 92. Sumitomo Dainippon Company Details
Table 93. Sumitomo Dainippon Business Overview
Table 94. Sumitomo Dainippon Drugs for Asthma and COPD Product
Table 95. Sumitomo Dainippon Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 96. Sumitomo Dainippon Recent Development
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Drugs for Asthma and COPD Product
Table 100. Merck Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Beximco Company Details
Table 103. Beximco Business Overview
Table 104. Beximco Drugs for Asthma and COPD Product
Table 105. Beximco Revenue in Drugs for Asthma and COPD Business (2020-2025) & (US$ Million)
Table 106. Beximco Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Drugs for Asthma and COPD Picture
Figure 2. Global Drugs for Asthma and COPD Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drugs for Asthma and COPD Market Share by Type: 2024 VS 2031
Figure 4. Inhalable & Nasal Spray Features
Figure 5. Oral Features
Figure 6. Others Features
Figure 7. Global Drugs for Asthma and COPD Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Drugs for Asthma and COPD Market Share by Application: 2024 VS 2031
Figure 9. Asthma Case Studies
Figure 10. COPD Case Studies
Figure 11. Drugs for Asthma and COPD Report Years Considered
Figure 12. Global Drugs for Asthma and COPD Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Drugs for Asthma and COPD Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Drugs for Asthma and COPD Market Share by Region: 2024 VS 2031
Figure 15. Global Drugs for Asthma and COPD Market Share by Players in 2024
Figure 16. Global Top Drugs for Asthma and COPD Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Asthma and COPD as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Drugs for Asthma and COPD Revenue in 2024
Figure 18. North America Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Drugs for Asthma and COPD Market Share by Country (2020-2031)
Figure 20. United States Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Drugs for Asthma and COPD Market Share by Country (2020-2031)
Figure 24. Germany Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Drugs for Asthma and COPD Market Share by Region (2020-2031)
Figure 32. China Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Drugs for Asthma and COPD Market Share by Country (2020-2031)
Figure 40. Mexico Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Drugs for Asthma and COPD Market Share by Country (2020-2031)
Figure 44. Turkey Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Drugs for Asthma and COPD Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. GSK Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 48. AstraZeneca Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 50. Vertex Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 51. Roche Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 53. Teva Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 54. Chiesi Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 55. Mylan Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 56. Sumitomo Dainippon Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 57. Merck Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 58. Beximco Revenue Growth Rate in Drugs for Asthma and COPD Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232